ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Renal Therapeutic Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-8O13640
Home | Market Reports | Health| Health Conditions
Global Renal Therapeutic Market Research Report 2023
BUY CHAPTERS

Global Renal Therapeutic Market Research Report 2025

Code: QYRE-Auto-8O13640
Report
January 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck& Co. Inc
Bristol Myers Squibb Company
Novartis
Pfizer Inc
Vifor Pharma Inc.
Johnson & Johnson Services Inc.
Amgen Inc
Bayer
Astrazeneca plc
Vifor Pharma Group
AbbVie
GlaxoSmithKline PLC
Sanofi

Renal Therapeutic Market Size

The global market for Renal Therapeutic was valued at US$ 2510 million in the year 2024 and is projected to reach a revised size of US$ 3978 million by 2031, growing at a CAGR of 6.9% during the forecast period.

Renal Therapeutic Market

Renal Therapeutic Market

Chronic kidney disease (CKD) is a slow and progressive loss of kidney function over several years. Eventually, a person may develop kidney failure.
The global renal therapeutic market refers to the market for drugs and therapies used in the treatment of renal (kidney) diseases and disorders. The prevalence of renal diseases, including chronic kidney disease (CKD), end-stage renal disease (ESRD), and various types of kidney-related disorders, has been increasing worldwide. Here are some key insights into the global renal therapeutic market:
Chronic Kidney Disease (CKD): CKD is a prevalent renal disease characterized by the gradual loss of kidney function over time. The rising incidence of CKD, primarily fueled by factors such as diabetes, hypertension, and aging populations, drives the demand for renal therapeutics. Medications that aim to slow disease progression and manage complications associated with CKD, such as anemia, bone disorders, and cardiovascular complications, are key components of the renal therapeutic market.
End-Stage Renal Disease (ESRD): ESRD represents the most advanced stage of kidney disease, where the kidneys have lost almost all their functioning ability. Renal replacement therapies, including dialysis and kidney transplantation, play a crucial role in managing ESRD patients’ health. Additionally, medications for managing secondary complications, such as anemia and mineral and bone disorders, are part of the renal therapeutic market.
Immunosuppressive Therapies: In the case of kidney transplantation, where a patient receives a new kidney, immunosuppressive therapies are vital to prevent organ rejection. These medications suppress the immune system to ensure the body does not attack the transplanted kidney. The demand for immunosuppressive drugs is high, and advancements in this area contribute to the growth of the renal therapeutic market.
Cardiovascular Complications: Kidney diseases are associated with an increased risk of cardiovascular complications, including hypertension, heart disease, and stroke. Renal therapeutics may include medications for managing these cardiovascular conditions to prevent further damage to the kidneys.
Market Players: The global renal therapeutic market is highly competitive, with several pharmaceutical companies operating in this space. Key players in the market include AbbVie Inc., Amgen Inc., AstraZeneca plc, Bayer AG, GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, Pfizer Inc., Sanofi S.A., and Vifor Pharma Group, among others. These companies engage in research and development activities, clinical trials, and marketing efforts to introduce innovative renal therapeutics to the market.
Technological Advancements: Continuous advancements in the field of renal therapeutics aim to provide more effective and targeted treatments. This includes the development of new drugs and therapies, improvements in drug delivery methods, and the exploration of novel therapeutic approaches, such as regenerative medicine and precision medicine, that have the potential to revolutionize renal disease management.
Geographical Trends: The demand for renal therapeutics varies across different regions. Developed countries, including North America and Europe, have a higher prevalence of kidney diseases and better access to healthcare, resulting in a higher demand for renal therapeutics. However, emerging economies in Asia-Pacific, Latin America, and the Middle East are expected to witness significant market growth due to improving healthcare infrastructure, increasing awareness, and a growing patient population.
The global renal therapeutic market is driven by the increasing prevalence of renal diseases and the need for effective treatment options. Advances in the field of renal therapeutics continue to improve patient outcomes and quality of life. As the burden of renal diseases grows, the market is likely to witness continued growth and innovation in the years to come.The global renal therapeutic market refers to the market for drugs and therapies used in the treatment of renal (kidney) diseases and disorders. The prevalence of renal diseases, including chronic kidney disease (CKD), end-stage renal disease (ESRD), and various types of kidney-related disorders, has been increasing worldwide. Here are some key insights into the global renal therapeutic market:
Chronic Kidney Disease (CKD): CKD is a prevalent renal disease characterized by the gradual loss of kidney function over time. The rising incidence of CKD, primarily fueled by factors such as diabetes, hypertension, and aging populations, drives the demand for renal therapeutics. Medications that aim to slow disease progression and manage complications associated with CKD, such as anemia, bone disorders, and cardiovascular complications, are key components of the renal therapeutic market.
End-Stage Renal Disease (ESRD): ESRD represents the most advanced stage of kidney disease, where the kidneys have lost almost all their functioning ability. Renal replacement therapies, including dialysis and kidney transplantation, play a crucial role in managing ESRD patients’ health. Additionally, medications for managing secondary complications, such as anemia and mineral and bone disorders, are part of the renal therapeutic market.
Immunosuppressive Therapies: In the case of kidney transplantation, where a patient receives a new kidney, immunosuppressive therapies are vital to prevent organ rejection. These medications suppress the immune system to ensure the body does not attack the transplanted kidney. The demand for immunosuppressive drugs is high, and advancements in this area contribute to the growth of the renal therapeutic market.
Cardiovascular Complications: Kidney diseases are associated with an increased risk of cardiovascular complications, including hypertension, heart disease, and stroke. Renal therapeutics may include medications for managing these cardiovascular conditions to prevent further damage to the kidneys.
Market Players: The global renal therapeutic market is highly competitive, with several pharmaceutical companies operating in this space. Key players in the market include AbbVie Inc., Amgen Inc., AstraZeneca plc, Bayer AG, GlaxoSmithKline plc, Johnson & Johnson, Novartis AG, Pfizer Inc., Sanofi S.A., and Vifor Pharma Group, among others. These companies engage in research and development activities, clinical trials, and marketing efforts to introduce innovative renal therapeutics to the market.
Technological Advancements: Continuous advancements in the field of renal therapeutics aim to provide more effective and targeted treatments. This includes the development of new drugs and therapies, improvements in drug delivery methods, and the exploration of novel therapeutic approaches, such as regenerative medicine and precision medicine, that have the potential to revolutionize renal disease management.
Geographical Trends: The demand for renal therapeutics varies across different regions. Developed countries, including North America and Europe, have a higher prevalence of kidney diseases and better access to healthcare, resulting in a higher demand for renal therapeutics. However, emerging economies in Asia-Pacific, Latin America, and the Middle East are expected to witness significant market growth due to improving healthcare infrastructure, increasing awareness, and a growing patient population.
The global renal therapeutic market is driven by the increasing prevalence of renal diseases and the need for effective treatment options. Advances in the field of renal therapeutics continue to improve patient outcomes and quality of life. As the burden of renal diseases grows, the market is likely to witness continued growth and innovation in the years to come.
This report aims to provide a comprehensive presentation of the global market for Renal Therapeutic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Renal Therapeutic.
The Renal Therapeutic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Renal Therapeutic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Renal Therapeutic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Renal Therapeutic Market Report

Report Metric Details
Report Name Renal Therapeutic Market
Accounted market size in year US$ 2510 million
Forecasted market size in 2031 US$ 3978 million
CAGR 6.9%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company AbbVie Inc, AstraZeneca plc, GlaxoSmithKline plc, Sanofi S.A, Merck & Co., Inc., Bristol-Myers Squibb Company, Novartis AG, Pfizer Inc., Vifor Pharma Inc., Johnson & Johnson Services, Inc., Amgen Inc., Bayer AG, AstraZeneca, Vifor Pharma Group
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Renal Therapeutic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Renal Therapeutic Market growing?

Ans: The Renal Therapeutic Market witnessing a CAGR of 6.9% during the forecast period 2025-2031.

What is the Renal Therapeutic Market size in 2031?

Ans: The Renal Therapeutic Market size in 2031 will be US$ 3978 million.

Who are the main players in the Renal Therapeutic Market report?

Ans: The main players in the Renal Therapeutic Market are AbbVie Inc, AstraZeneca plc, GlaxoSmithKline plc, Sanofi S.A, Merck & Co., Inc., Bristol-Myers Squibb Company, Novartis AG, Pfizer Inc., Vifor Pharma Inc., Johnson & Johnson Services, Inc., Amgen Inc., Bayer AG, AstraZeneca, Vifor Pharma Group

What are the Application segmentation covered in the Renal Therapeutic Market report?

Ans: The Applications covered in the Renal Therapeutic Market report are Chronic Kidney Disease, Diabetes, Kidney Stone Disease, Renal Failure, Others

What are the Type segmentation covered in the Renal Therapeutic Market report?

Ans: The Types covered in the Renal Therapeutic Market report are Angiotensin-II Receptor Blockers, ACE Inhibitors, Calcium Channel Blockers, Beta-blockers, Others

Recommended Reports

Kidney Disease Drugs

Kidney Disease Therapy

Kidney Disease Diagnosis

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Renal Therapeutic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Angiotensin-II Receptor Blockers
1.2.3 ACE Inhibitors
1.2.4 Calcium Channel Blockers
1.2.5 Beta-blockers
1.2.6 Others
1.3 Market by Application
1.3.1 Global Renal Therapeutic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Chronic Kidney Disease
1.3.3 Diabetes
1.3.4 Kidney Stone Disease
1.3.5 Renal Failure
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Renal Therapeutic Market Perspective (2020-2031)
2.2 Global Renal Therapeutic Growth Trends by Region
2.2.1 Global Renal Therapeutic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Renal Therapeutic Historic Market Size by Region (2020-2025)
2.2.3 Renal Therapeutic Forecasted Market Size by Region (2026-2031)
2.3 Renal Therapeutic Market Dynamics
2.3.1 Renal Therapeutic Industry Trends
2.3.2 Renal Therapeutic Market Drivers
2.3.3 Renal Therapeutic Market Challenges
2.3.4 Renal Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Renal Therapeutic Players by Revenue
3.1.1 Global Top Renal Therapeutic Players by Revenue (2020-2025)
3.1.2 Global Renal Therapeutic Revenue Market Share by Players (2020-2025)
3.2 Global Renal Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Renal Therapeutic Revenue
3.4 Global Renal Therapeutic Market Concentration Ratio
3.4.1 Global Renal Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Renal Therapeutic Revenue in 2024
3.5 Global Key Players of Renal Therapeutic Head office and Area Served
3.6 Global Key Players of Renal Therapeutic, Product and Application
3.7 Global Key Players of Renal Therapeutic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Renal Therapeutic Breakdown Data by Type
4.1 Global Renal Therapeutic Historic Market Size by Type (2020-2025)
4.2 Global Renal Therapeutic Forecasted Market Size by Type (2026-2031)
5 Renal Therapeutic Breakdown Data by Application
5.1 Global Renal Therapeutic Historic Market Size by Application (2020-2025)
5.2 Global Renal Therapeutic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Renal Therapeutic Market Size (2020-2031)
6.2 North America Renal Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Renal Therapeutic Market Size by Country (2020-2025)
6.4 North America Renal Therapeutic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Renal Therapeutic Market Size (2020-2031)
7.2 Europe Renal Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Renal Therapeutic Market Size by Country (2020-2025)
7.4 Europe Renal Therapeutic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Renal Therapeutic Market Size (2020-2031)
8.2 Asia-Pacific Renal Therapeutic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Renal Therapeutic Market Size by Region (2020-2025)
8.4 Asia-Pacific Renal Therapeutic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Renal Therapeutic Market Size (2020-2031)
9.2 Latin America Renal Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Renal Therapeutic Market Size by Country (2020-2025)
9.4 Latin America Renal Therapeutic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Renal Therapeutic Market Size (2020-2031)
10.2 Middle East & Africa Renal Therapeutic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Renal Therapeutic Market Size by Country (2020-2025)
10.4 Middle East & Africa Renal Therapeutic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie Inc
11.1.1 AbbVie Inc Company Details
11.1.2 AbbVie Inc Business Overview
11.1.3 AbbVie Inc Renal Therapeutic Introduction
11.1.4 AbbVie Inc Revenue in Renal Therapeutic Business (2020-2025)
11.1.5 AbbVie Inc Recent Development
11.2 AstraZeneca plc
11.2.1 AstraZeneca plc Company Details
11.2.2 AstraZeneca plc Business Overview
11.2.3 AstraZeneca plc Renal Therapeutic Introduction
11.2.4 AstraZeneca plc Revenue in Renal Therapeutic Business (2020-2025)
11.2.5 AstraZeneca plc Recent Development
11.3 GlaxoSmithKline plc
11.3.1 GlaxoSmithKline plc Company Details
11.3.2 GlaxoSmithKline plc Business Overview
11.3.3 GlaxoSmithKline plc Renal Therapeutic Introduction
11.3.4 GlaxoSmithKline plc Revenue in Renal Therapeutic Business (2020-2025)
11.3.5 GlaxoSmithKline plc Recent Development
11.4 Sanofi S.A
11.4.1 Sanofi S.A Company Details
11.4.2 Sanofi S.A Business Overview
11.4.3 Sanofi S.A Renal Therapeutic Introduction
11.4.4 Sanofi S.A Revenue in Renal Therapeutic Business (2020-2025)
11.4.5 Sanofi S.A Recent Development
11.5 Merck & Co., Inc.
11.5.1 Merck & Co., Inc. Company Details
11.5.2 Merck & Co., Inc. Business Overview
11.5.3 Merck & Co., Inc. Renal Therapeutic Introduction
11.5.4 Merck & Co., Inc. Revenue in Renal Therapeutic Business (2020-2025)
11.5.5 Merck & Co., Inc. Recent Development
11.6 Bristol-Myers Squibb Company
11.6.1 Bristol-Myers Squibb Company Company Details
11.6.2 Bristol-Myers Squibb Company Business Overview
11.6.3 Bristol-Myers Squibb Company Renal Therapeutic Introduction
11.6.4 Bristol-Myers Squibb Company Revenue in Renal Therapeutic Business (2020-2025)
11.6.5 Bristol-Myers Squibb Company Recent Development
11.7 Novartis AG
11.7.1 Novartis AG Company Details
11.7.2 Novartis AG Business Overview
11.7.3 Novartis AG Renal Therapeutic Introduction
11.7.4 Novartis AG Revenue in Renal Therapeutic Business (2020-2025)
11.7.5 Novartis AG Recent Development
11.8 Pfizer Inc.
11.8.1 Pfizer Inc. Company Details
11.8.2 Pfizer Inc. Business Overview
11.8.3 Pfizer Inc. Renal Therapeutic Introduction
11.8.4 Pfizer Inc. Revenue in Renal Therapeutic Business (2020-2025)
11.8.5 Pfizer Inc. Recent Development
11.9 Vifor Pharma Inc.
11.9.1 Vifor Pharma Inc. Company Details
11.9.2 Vifor Pharma Inc. Business Overview
11.9.3 Vifor Pharma Inc. Renal Therapeutic Introduction
11.9.4 Vifor Pharma Inc. Revenue in Renal Therapeutic Business (2020-2025)
11.9.5 Vifor Pharma Inc. Recent Development
11.10 Johnson & Johnson Services, Inc.
11.10.1 Johnson & Johnson Services, Inc. Company Details
11.10.2 Johnson & Johnson Services, Inc. Business Overview
11.10.3 Johnson & Johnson Services, Inc. Renal Therapeutic Introduction
11.10.4 Johnson & Johnson Services, Inc. Revenue in Renal Therapeutic Business (2020-2025)
11.10.5 Johnson & Johnson Services, Inc. Recent Development
11.11 Amgen Inc.
11.11.1 Amgen Inc. Company Details
11.11.2 Amgen Inc. Business Overview
11.11.3 Amgen Inc. Renal Therapeutic Introduction
11.11.4 Amgen Inc. Revenue in Renal Therapeutic Business (2020-2025)
11.11.5 Amgen Inc. Recent Development
11.12 Bayer AG
11.12.1 Bayer AG Company Details
11.12.2 Bayer AG Business Overview
11.12.3 Bayer AG Renal Therapeutic Introduction
11.12.4 Bayer AG Revenue in Renal Therapeutic Business (2020-2025)
11.12.5 Bayer AG Recent Development
11.13 AstraZeneca
11.13.1 AstraZeneca Company Details
11.13.2 AstraZeneca Business Overview
11.13.3 AstraZeneca Renal Therapeutic Introduction
11.13.4 AstraZeneca Revenue in Renal Therapeutic Business (2020-2025)
11.13.5 AstraZeneca Recent Development
11.14 Vifor Pharma Group
11.14.1 Vifor Pharma Group Company Details
11.14.2 Vifor Pharma Group Business Overview
11.14.3 Vifor Pharma Group Renal Therapeutic Introduction
11.14.4 Vifor Pharma Group Revenue in Renal Therapeutic Business (2020-2025)
11.14.5 Vifor Pharma Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Merck& Co. Inc
Bristol Myers Squibb Company
Novartis
Pfizer Inc
Vifor Pharma Inc.
Johnson & Johnson Services Inc.
Amgen Inc
Bayer
Astrazeneca plc
Vifor Pharma Group
AbbVie
GlaxoSmithKline PLC
Sanofi
List of Tables
 Table 1. Global Renal Therapeutic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Angiotensin-II Receptor Blockers
 Table 3. Key Players of ACE Inhibitors
 Table 4. Key Players of Calcium Channel Blockers
 Table 5. Key Players of Beta-blockers
 Table 6. Key Players of Others
 Table 7. Global Renal Therapeutic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Renal Therapeutic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global Renal Therapeutic Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global Renal Therapeutic Market Share by Region (2020-2025)
 Table 11. Global Renal Therapeutic Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global Renal Therapeutic Market Share by Region (2026-2031)
 Table 13. Renal Therapeutic Market Trends
 Table 14. Renal Therapeutic Market Drivers
 Table 15. Renal Therapeutic Market Challenges
 Table 16. Renal Therapeutic Market Restraints
 Table 17. Global Renal Therapeutic Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global Renal Therapeutic Market Share by Players (2020-2025)
 Table 19. Global Top Renal Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Therapeutic as of 2024)
 Table 20. Ranking of Global Top Renal Therapeutic Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by Renal Therapeutic Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of Renal Therapeutic, Headquarters and Area Served
 Table 23. Global Key Players of Renal Therapeutic, Product and Application
 Table 24. Global Key Players of Renal Therapeutic, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global Renal Therapeutic Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global Renal Therapeutic Revenue Market Share by Type (2020-2025)
 Table 28. Global Renal Therapeutic Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global Renal Therapeutic Revenue Market Share by Type (2026-2031)
 Table 30. Global Renal Therapeutic Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global Renal Therapeutic Revenue Market Share by Application (2020-2025)
 Table 32. Global Renal Therapeutic Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global Renal Therapeutic Revenue Market Share by Application (2026-2031)
 Table 34. North America Renal Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America Renal Therapeutic Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America Renal Therapeutic Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe Renal Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe Renal Therapeutic Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe Renal Therapeutic Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific Renal Therapeutic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific Renal Therapeutic Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific Renal Therapeutic Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America Renal Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America Renal Therapeutic Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America Renal Therapeutic Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa Renal Therapeutic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa Renal Therapeutic Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa Renal Therapeutic Market Size by Country (2026-2031) & (US$ Million)
 Table 49. AbbVie Inc Company Details
 Table 50. AbbVie Inc Business Overview
 Table 51. AbbVie Inc Renal Therapeutic Product
 Table 52. AbbVie Inc Revenue in Renal Therapeutic Business (2020-2025) & (US$ Million)
 Table 53. AbbVie Inc Recent Development
 Table 54. AstraZeneca plc Company Details
 Table 55. AstraZeneca plc Business Overview
 Table 56. AstraZeneca plc Renal Therapeutic Product
 Table 57. AstraZeneca plc Revenue in Renal Therapeutic Business (2020-2025) & (US$ Million)
 Table 58. AstraZeneca plc Recent Development
 Table 59. GlaxoSmithKline plc Company Details
 Table 60. GlaxoSmithKline plc Business Overview
 Table 61. GlaxoSmithKline plc Renal Therapeutic Product
 Table 62. GlaxoSmithKline plc Revenue in Renal Therapeutic Business (2020-2025) & (US$ Million)
 Table 63. GlaxoSmithKline plc Recent Development
 Table 64. Sanofi S.A Company Details
 Table 65. Sanofi S.A Business Overview
 Table 66. Sanofi S.A Renal Therapeutic Product
 Table 67. Sanofi S.A Revenue in Renal Therapeutic Business (2020-2025) & (US$ Million)
 Table 68. Sanofi S.A Recent Development
 Table 69. Merck & Co., Inc. Company Details
 Table 70. Merck & Co., Inc. Business Overview
 Table 71. Merck & Co., Inc. Renal Therapeutic Product
 Table 72. Merck & Co., Inc. Revenue in Renal Therapeutic Business (2020-2025) & (US$ Million)
 Table 73. Merck & Co., Inc. Recent Development
 Table 74. Bristol-Myers Squibb Company Company Details
 Table 75. Bristol-Myers Squibb Company Business Overview
 Table 76. Bristol-Myers Squibb Company Renal Therapeutic Product
 Table 77. Bristol-Myers Squibb Company Revenue in Renal Therapeutic Business (2020-2025) & (US$ Million)
 Table 78. Bristol-Myers Squibb Company Recent Development
 Table 79. Novartis AG Company Details
 Table 80. Novartis AG Business Overview
 Table 81. Novartis AG Renal Therapeutic Product
 Table 82. Novartis AG Revenue in Renal Therapeutic Business (2020-2025) & (US$ Million)
 Table 83. Novartis AG Recent Development
 Table 84. Pfizer Inc. Company Details
 Table 85. Pfizer Inc. Business Overview
 Table 86. Pfizer Inc. Renal Therapeutic Product
 Table 87. Pfizer Inc. Revenue in Renal Therapeutic Business (2020-2025) & (US$ Million)
 Table 88. Pfizer Inc. Recent Development
 Table 89. Vifor Pharma Inc. Company Details
 Table 90. Vifor Pharma Inc. Business Overview
 Table 91. Vifor Pharma Inc. Renal Therapeutic Product
 Table 92. Vifor Pharma Inc. Revenue in Renal Therapeutic Business (2020-2025) & (US$ Million)
 Table 93. Vifor Pharma Inc. Recent Development
 Table 94. Johnson & Johnson Services, Inc. Company Details
 Table 95. Johnson & Johnson Services, Inc. Business Overview
 Table 96. Johnson & Johnson Services, Inc. Renal Therapeutic Product
 Table 97. Johnson & Johnson Services, Inc. Revenue in Renal Therapeutic Business (2020-2025) & (US$ Million)
 Table 98. Johnson & Johnson Services, Inc. Recent Development
 Table 99. Amgen Inc. Company Details
 Table 100. Amgen Inc. Business Overview
 Table 101. Amgen Inc. Renal Therapeutic Product
 Table 102. Amgen Inc. Revenue in Renal Therapeutic Business (2020-2025) & (US$ Million)
 Table 103. Amgen Inc. Recent Development
 Table 104. Bayer AG Company Details
 Table 105. Bayer AG Business Overview
 Table 106. Bayer AG Renal Therapeutic Product
 Table 107. Bayer AG Revenue in Renal Therapeutic Business (2020-2025) & (US$ Million)
 Table 108. Bayer AG Recent Development
 Table 109. AstraZeneca Company Details
 Table 110. AstraZeneca Business Overview
 Table 111. AstraZeneca Renal Therapeutic Product
 Table 112. AstraZeneca Revenue in Renal Therapeutic Business (2020-2025) & (US$ Million)
 Table 113. AstraZeneca Recent Development
 Table 114. Vifor Pharma Group Company Details
 Table 115. Vifor Pharma Group Business Overview
 Table 116. Vifor Pharma Group Renal Therapeutic Product
 Table 117. Vifor Pharma Group Revenue in Renal Therapeutic Business (2020-2025) & (US$ Million)
 Table 118. Vifor Pharma Group Recent Development
 Table 119. Research Programs/Design for This Report
 Table 120. Key Data Information from Secondary Sources
 Table 121. Key Data Information from Primary Sources
 Table 122. Authors List of This Report


List of Figures
 Figure 1. Renal Therapeutic Picture
 Figure 2. Global Renal Therapeutic Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Renal Therapeutic Market Share by Type: 2024 VS 2031
 Figure 4. Angiotensin-II Receptor Blockers Features
 Figure 5. ACE Inhibitors Features
 Figure 6. Calcium Channel Blockers Features
 Figure 7. Beta-blockers Features
 Figure 8. Others Features
 Figure 9. Global Renal Therapeutic Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global Renal Therapeutic Market Share by Application: 2024 VS 2031
 Figure 11. Chronic Kidney Disease Case Studies
 Figure 12. Diabetes Case Studies
 Figure 13. Kidney Stone Disease Case Studies
 Figure 14. Renal Failure Case Studies
 Figure 15. Others Case Studies
 Figure 16. Renal Therapeutic Report Years Considered
 Figure 17. Global Renal Therapeutic Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 18. Global Renal Therapeutic Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 19. Global Renal Therapeutic Market Share by Region: 2024 VS 2031
 Figure 20. Global Renal Therapeutic Market Share by Players in 2024
 Figure 21. Global Top Renal Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Therapeutic as of 2024)
 Figure 22. The Top 10 and 5 Players Market Share by Renal Therapeutic Revenue in 2024
 Figure 23. North America Renal Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. North America Renal Therapeutic Market Share by Country (2020-2031)
 Figure 25. United States Renal Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Canada Renal Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe Renal Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Europe Renal Therapeutic Market Share by Country (2020-2031)
 Figure 29. Germany Renal Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. France Renal Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. U.K. Renal Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Italy Renal Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Russia Renal Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Nordic Countries Renal Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific Renal Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Asia-Pacific Renal Therapeutic Market Share by Region (2020-2031)
 Figure 37. China Renal Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Japan Renal Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. South Korea Renal Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Renal Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. India Renal Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Australia Renal Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America Renal Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Latin America Renal Therapeutic Market Share by Country (2020-2031)
 Figure 45. Mexico Renal Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Brazil Renal Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa Renal Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Middle East & Africa Renal Therapeutic Market Share by Country (2020-2031)
 Figure 49. Turkey Renal Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Renal Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. UAE Renal Therapeutic Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 52. AbbVie Inc Revenue Growth Rate in Renal Therapeutic Business (2020-2025)
 Figure 53. AstraZeneca plc Revenue Growth Rate in Renal Therapeutic Business (2020-2025)
 Figure 54. GlaxoSmithKline plc Revenue Growth Rate in Renal Therapeutic Business (2020-2025)
 Figure 55. Sanofi S.A Revenue Growth Rate in Renal Therapeutic Business (2020-2025)
 Figure 56. Merck & Co., Inc. Revenue Growth Rate in Renal Therapeutic Business (2020-2025)
 Figure 57. Bristol-Myers Squibb Company Revenue Growth Rate in Renal Therapeutic Business (2020-2025)
 Figure 58. Novartis AG Revenue Growth Rate in Renal Therapeutic Business (2020-2025)
 Figure 59. Pfizer Inc. Revenue Growth Rate in Renal Therapeutic Business (2020-2025)
 Figure 60. Vifor Pharma Inc. Revenue Growth Rate in Renal Therapeutic Business (2020-2025)
 Figure 61. Johnson & Johnson Services, Inc. Revenue Growth Rate in Renal Therapeutic Business (2020-2025)
 Figure 62. Amgen Inc. Revenue Growth Rate in Renal Therapeutic Business (2020-2025)
 Figure 63. Bayer AG Revenue Growth Rate in Renal Therapeutic Business (2020-2025)
 Figure 64. AstraZeneca Revenue Growth Rate in Renal Therapeutic Business (2020-2025)
 Figure 65. Vifor Pharma Group Revenue Growth Rate in Renal Therapeutic Business (2020-2025)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Lukasiewicz Research Network

SIMILAR REPORTS

Chronic Kidney Disease CKD Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chronic Kidney Disease CKD Treatment Market Research Report 2025
Global End Stage Kidney Disease Market Research Report 2024
Global Chronic Kidney Disease Treatment Market Research Report 2025
Global Chronic Kidney Disease Medication Market Research Report 2024
Global End Stage Renal Disease Market Research Report 2024
Global CKD and ESRD Treatment Market Research Report 2025
Global Late Stage Chronic Kidney Disease Therapeutics Market Research Report 2024
Global Drugs to Treat Chronic Kidney Disease Market Research Report 2024
Global End Stage Renal Disease ESRD Device Market Research Report 2024
Global End Stage Renal Disease ESRD Treatment Market Research Report 2025
Global Renal Diseases Drug Market Insights Forecast to 2030
Late Stage Chronic Kidney Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Kidney Renal Fibrosis Treatment Market Insights Forecast to 2030
Global End stage Renal Disease Therapeutics Market Research Report 2024
Global Chronic Kidney Disease Nutritional Supplement Market Research Report 2024
Global IT Solution for Dialysis Market Research Report 2024
End Stage Renal Disease ESRD Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chronic Kidney Disease Mineral and Bone Disorders CKD MBD Market Research Report 2024
End Stage Renal Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Insulin Coolers Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19Z7671
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Ossicular Prostheses Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10V14317
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Defibrillator Accessories Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10O5919
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Septicemia Diagnostic Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4I19963
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions